Identification of myeloid-derived growth factor as a mechanically-induced, growth-promoting angiocrine signal for human hepatocytes
Linda Große-Segerath,Paula Follert,Kristina Behnke,Julia Ettich,Tobias Buschmann,Philip Kirschner,Sonja Hartwig,Stefan Lehr,Mortimer Korf-Klingebiel,Daniel Eberhard,Nadja Lehwald-Tywuschik,Hadi Al-Hasani,Wolfram Trudo Knoefel,Stefan Heinrich,Bodo Levkau,Kai C. Wollert,Jürgen Scheller,Eckhard Lammert
DOI: https://doi.org/10.1038/s41467-024-44760-y
IF: 16.6
2024-02-05
Nature Communications
Abstract:Abstract Recently, we have shown that after partial hepatectomy (PHx), an increased hepatic blood flow initiates liver growth in mice by vasodilation and mechanically-triggered release of angiocrine signals. Here, we use mass spectrometry to identify a mechanically-induced angiocrine signal in human hepatic endothelial cells, that is, myeloid-derived growth factor (MYDGF). We show that it induces proliferation and promotes survival of primary human hepatocytes derived from different donors in two-dimensional cell culture, via activation of mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3). MYDGF also enhances proliferation of human hepatocytes in three-dimensional organoids. In vivo, genetic deletion of MYDGF decreases hepatocyte proliferation in the regenerating mouse liver after PHx; conversely, adeno-associated viral delivery of MYDGF increases hepatocyte proliferation and MAPK signaling after PHx. We conclude that MYDGF represents a mechanically-induced angiocrine signal and that it triggers growth of, and provides protection to, primary mouse and human hepatocytes.
multidisciplinary sciences